Long-term treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after stopping second-line (2L) nilotinib: ENESTop 144-wk results.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: François-Xavier Mahon, Carla Boquimpani, Naoto Takahashi, Noam Benyamini, Nelma Cristina D. Clementino, Vasily Shuvaev, Akil Merchant, Jeffrey H. Lipton, Anna G. Turkina, Raquel De Paz Arias, Beatriz Moiraghi, Franck E. Nicolini, Jolanta Dengler, Tomasz Sacha, Dong-Wook Kim, Rafik Fellague-Chebra, Sandip Acharya, Shalini Chaturvedi, Catherine Bouard, Timothy P. Hughes
Institutions: Université de Bordeaux, Inserm, Institut Bergonié, Hemorio, Akita University, Akita University Hospital, Rambam Health Care Campus, Hospital das Clínicas da Universidade Federal de Minas Gerais, Russian Research Institute of Hematology and Transfusiology, University of Southern California, University of Toronto, Princess Margaret Cancer Centre, National Medical Research Center for Hematology, Hospital Universitario La Paz, Hospital Ramos Mejía, Centre Léon Bérard, Jagiellonian University, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Novartis (France), Novartis (India), Novartis (Switzerland), South Australia Pathology, South Australian Health and Medical Research Institute, The University of Adelaide
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891287398